Literature DB >> 33705536

Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases.

Bharati Kochar1,2,3, Lakshman Kalasapudi4, Nneka N Ufere1,2,3, Ryan D Nipp2,3,5, Ashwin N Ananthakrishnan1,2,3, Christine S Ritchie2,3,6.   

Abstract

Entities:  

Keywords:  Crohn’s disease; aging; clinical trials; treatment; ulcerative colitis

Mesh：

Year:  2021        PMID： 33705536     DOI： 10.1093/ibd/izab052

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  3 in total

1.  Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults.

Authors:  Bharati Kochar; Virginia Pate; Michael D Kappelman; Millie D Long; Ashwin N Ananthakrishnan; Andrew T Chan; Robert S Sandler
Journal:  Clin Gastroenterol Hepatol       Date:  2021-09-03       Impact factor: 13.576

Review 2.  Ulcerative Colitis in Adulthood and in Older Patients: Same Disease, Same Outcome, Same Risks?

Authors:  Walter Fries; Maria Giulia Demarzo; Giuseppe Navarra; Anna Viola
Journal:  Drugs Aging       Date:  2022-06-01       Impact factor: 4.271

3.  The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis.

Authors:  Bharati Kochar; Nneka N Ufere; Christine S Ritchie; Jennifer C Lai
Journal:  Clin Transl Gastroenterol       Date:  2022-01-12       Impact factor: 4.396
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.